Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PLK-1 inhibitors for the treatment of cancer described by Roche

Feb. 19, 2010

Merck KGaA discloses novel SphK1 and Met kinase inhibitors

Feb. 18, 2010

Georgetown University discloses MLCP inhibitors for cancer therapy

Feb. 18, 2010

Crystal structure of PI3Kdelta in complex with inhibitors allows design of enhanced agents

Feb. 18, 2010

Wyeth discloses the discovery of novel PARP-1 inhibitors

Feb. 17, 2010

Novel selective and orally active inhibitors of PKB show potent antitumor effects in vivo

Feb. 17, 2010

FDA approves REMS for erythropoiesis-stimulating agents

Feb. 17, 2010

U.K. MHRA approves Oncolytics' phase III trial of Reolysin in head and neck cancers

Feb. 17, 2010

Tyrosine kinase inhibitors for cancer therapy disclosed by Merck KGaA

Feb. 17, 2010

TopoTarget discloses novel NMPRTase inhibitors

Feb. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...